MedPath

To study the effectiveness of vancomycin medicine treatment in patients who are likely to have gram positive bacterial infection admitted to medicine intensive care unit

Phase 4
Completed
Conditions
Health Condition 1: null- Admitted to Medicine Intensive Care Unit with suspected or proven bacterial infection
Registration Number
CTRI/2015/11/006393
Lead Sponsor
Seth GSMC and KEM Hospital mumbai
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
Not specified
Target Recruitment
15
Inclusion Criteria

1.Written, signed, dated and institutional ethics committee approved informed consent obtained from patients or legally acceptable representative before performing any screening procedures

2.Patients with suspected or proven Gram â?? positive bacterial infection

Exclusion Criteria

1.Patients with hypersensitivity to vancomycin hydrochloride or any excipients of its formulation

2.Patient receiving vancomycin therapy

3.Participation in any investigational study within 30 days prior to screening

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath